Naproxen Ec Mylan

Naproxen, the active ingredient in Naproxen Ec Mylan, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It is used to relieve pain, reduce inflammation, and lower fever in adults and adolescents for conditions such as arthritis, dysmenorrhea, and musculoskeletal injuries.

GNH USA supplies Naproxen Ec Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that reduces inflammation and pain by inhibiting cyclooxygenase enzymes. - Pain: provides analgesic relief for mild to moderate acute pain. - Inflammation: decreases swelling and stiffness associated with inflammatory conditions. - Arthritis: helps control symptoms of osteoarthritis and rheumatoid arthritis. - Dysmenorrhea: alleviates menstrual cramps and associated discomfort.

Naproxen may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Stomach upset or dyspepsia - Nausea or vomiting - Headache - Dizziness - Mild skin rash - Diarrhoea

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe cardiovascular events such as myocardial infarction - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic enzyme elevation or liver injury - Acute kidney injury or renal failure - Anaphylaxis or severe allergic reactions

Before initiating therapy, consider patient‑specific risk factors and monitor appropriately. - Assess gastrointestinal risk: evaluate history of ulcers, bleeding, or chronic NSAID use. - Evaluate cardiovascular profile: avoid in patients with uncontrolled hypertension or recent thrombotic events. - Review renal function: adjust use in patients with impaired kidney function. - Monitor hepatic status: check liver enzymes if prolonged therapy is planned. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Naproxen can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleeding risk. - Lithium: naproxen may raise lithium serum levels. - Diuretics (especially thiazides): may reduce renal clearance of naproxen. - Methotrexate: naproxen can increase methotrexate toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may impair renal function. - Beta‑blockers: possible reduction in antihypertensive effect. - Corticosteroids: additive risk of gastrointestinal ulceration. - Antihypertensives: potential attenuation of blood pressure control. - Alcohol: synergistic increase in gastrointestinal irritation.